357 related articles for article (PubMed ID: 38236444)
1. Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship.
Maji L; Sengupta S; Purawarga Matada GS; Teli G; Biswas G; Das PK; Panduranga Mudgal M
Mol Divers; 2024 Jan; ():. PubMed ID: 38236444
[TBL] [Abstract][Full Text] [Related]
2. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
[TBL] [Abstract][Full Text] [Related]
3. Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors.
Welsch K; Holstein J; Laurence A; Ghoreschi K
Eur J Immunol; 2017 Jul; 47(7):1096-1107. PubMed ID: 28555727
[TBL] [Abstract][Full Text] [Related]
4. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.
Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D
Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling.
Fiebelkow J; Guendel A; Guendel B; Mehwald N; Jetka T; Komorowski M; Waldherr S; Schaper F; Dittrich A
Cell Commun Signal; 2021 Sep; 19(1):94. PubMed ID: 34530865
[TBL] [Abstract][Full Text] [Related]
6. The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease.
Lashgari NA; Roudsari NM; Momtaz S; Sathyapalan T; Abdolghaffari AH; Sahebkar A
J Neuroimmunol; 2021 Dec; 361():577758. PubMed ID: 34739911
[TBL] [Abstract][Full Text] [Related]
7. JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases.
Gao Q; Liang X; Shaikh AS; Zang J; Xu W; Zhang Y
Curr Drug Targets; 2018; 19(5):487-500. PubMed ID: 27928945
[TBL] [Abstract][Full Text] [Related]
8. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
[TBL] [Abstract][Full Text] [Related]
9. JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
Banerjee S; Biehl A; Gadina M; Hasni S; Schwartz DM
Drugs; 2017 Apr; 77(5):521-546. PubMed ID: 28255960
[TBL] [Abstract][Full Text] [Related]
10. Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
Favoino E; Prete M; Catacchio G; Ruscitti P; Navarini L; Giacomelli R; Perosa F
Autoimmun Rev; 2021 Mar; 20(3):102750. PubMed ID: 33482338
[TBL] [Abstract][Full Text] [Related]
11. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms.
Liu J; Wang F; Luo F
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671504
[TBL] [Abstract][Full Text] [Related]
12. Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis.
Kopalli SR; Annamneedi VP; Koppula S
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889539
[TBL] [Abstract][Full Text] [Related]
13. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
15. JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy.
Satarker S; Tom AA; Shaji RA; Alosious A; Luvis M; Nampoothiri M
Postgrad Med; 2021 Jun; 133(5):489-507. PubMed ID: 33245005
[TBL] [Abstract][Full Text] [Related]
16. The JAK/STAT signaling pathway: from bench to clinic.
Hu X; Li J; Fu M; Zhao X; Wang W
Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
[TBL] [Abstract][Full Text] [Related]
17. JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases.
Godoi MA; Camilli AC; Gonzales KGA; Costa VB; Papathanasiou E; Leite FRM; Guimarães-Stabili MR
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373437
[TBL] [Abstract][Full Text] [Related]
18. The regulation of JAKs in cytokine signaling and its breakdown in disease.
Hammarén HM; Virtanen AT; Raivola J; Silvennoinen O
Cytokine; 2019 Jun; 118():48-63. PubMed ID: 29685781
[TBL] [Abstract][Full Text] [Related]
19. JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens.
Hu Q; Bian Q; Rong D; Wang L; Song J; Huang HS; Zeng J; Mei J; Wang PY
Front Bioeng Biotechnol; 2023; 11():1110765. PubMed ID: 36911202
[TBL] [Abstract][Full Text] [Related]
20. The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis.
Morris R; Butler L; Perkins A; Kershaw NJ; Babon JJ
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
